Grant Sweep

Consolidated research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenR21Clinical trial: Not allowed

Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)

National Institutes of Health (NIH) · NIH Institute/Center · PAR-25-113

Source: Grants.gov · View original posting ↗

Award
Amount not listed
Deadline
Sep 7, 2027
Letter of intent
Mechanism
R21
Duration
Expected awards
Funding cycle
Standard NIH dates
Open date
Nov 18, 2024
Total funding
Clinical trial
Not allowed
Higher educationGovernmentNonprofitSmall businessForeign entities

Funding context

16%of applications funded

Based on FY2024 NIH (all institutes) R21 applications (1,837 of 11,592 applications awarded).

Institute-specific data wasn’t available — showing the NIH-wide rate for this mechanism.

Payline: NIH discontinued percentile paylines for 2026 under its Unified Funding Strategy ↗ — scores are now weighed in context rather than against a fixed cutoff.

NIH-wide R21, all institutes.

Aggregate historical data by institute, mechanism, and fiscal year — context for planning, not a prediction for this opportunity. Source ↗

Description

The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language development in children and that focuses on the development of novel measures of childrens language development. The overall goal is to build the number of strengths-focused, culturally and linguistically responsive, and generalizable toolsto further our understanding of childrens language development and/or impairment, and predictors thereof.

Data notes: award amount not published in the source feed; administering NIH institute could not be identified from the opportunity number.